Click for best price

RNA Vaccines Market Size, Share 2022

Market Analysis and Insights: Global RNA Vaccines Market

The global RNA Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global RNA Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global RNA Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global RNA Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global RNA Vaccines market.

Global RNA Vaccines Scope and Market Size

RNA Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global RNA Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Individualized Cancer Treatment MRNA Vaccine

Infectious Disease Treatment MRNA Vaccine

Infection Prevention MRNA Vaccine

Segment by Application

Infectious Disease

Cancer

Other

By Company

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes RNA Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of RNA Vaccines, with price, sales, revenue, and global market share of RNA Vaccines from 2019 to 2022.

Chapter 3, the RNA Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the RNA Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the RNA Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of RNA Vaccines.

Chapter 13, 14, and 15, to describe RNA Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 RNA Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global RNA Vaccines Market Insights, Forecast to 2028
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	107 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Study Coverage
1.1 RNA Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global RNA Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Market by Application
1.3.1 Global RNA Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global RNA Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global RNA Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global RNA Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global RNA Vaccines Sales by Region
2.4.1 Global RNA Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales RNA Vaccines by Region (2023-2028)
2.5 Global RNA Vaccines Revenue by Region
2.5.1 Global RNA Vaccines Revenue by Region (2017-2022)
2.5.2 Global RNA Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global RNA Vaccines Sales by Manufacturers
3.1.1 Global Top RNA Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global RNA Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of RNA Vaccines in 2021
3.2 Global RNA Vaccines Revenue by Manufacturers
3.2.1 Global RNA Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global RNA Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by RNA Vaccines Revenue in 2021
3.3 Global RNA Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global RNA Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global RNA Vaccines Sales by Type
4.1.1 Global RNA Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global RNA Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global RNA Vaccines Sales Market Share by Type (2017-2028)
4.2 Global RNA Vaccines Revenue by Type
4.2.1 Global RNA Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global RNA Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global RNA Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global RNA Vaccines Price by Type
4.3.1 Global RNA Vaccines Price by Type (2017-2022)
4.3.2 Global RNA Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global RNA Vaccines Sales by Application
5.1.1 Global RNA Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global RNA Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global RNA Vaccines Sales Market Share by Application (2017-2028)
5.2 Global RNA Vaccines Revenue by Application
5.2.1 Global RNA Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global RNA Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global RNA Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global RNA Vaccines Price by Application
5.3.1 Global RNA Vaccines Price by Application (2017-2022)
5.3.2 Global RNA Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America RNA Vaccines Market Size by Type
6.1.1 North America RNA Vaccines Sales by Type (2017-2028)
6.1.2 North America RNA Vaccines Revenue by Type (2017-2028)
6.2 North America RNA Vaccines Market Size by Application
6.2.1 North America RNA Vaccines Sales by Application (2017-2028)
6.2.2 North America RNA Vaccines Revenue by Application (2017-2028)
6.3 North America RNA Vaccines Market Size by Country
6.3.1 North America RNA Vaccines Sales by Country (2017-2028)
6.3.2 North America RNA Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe RNA Vaccines Market Size by Type
7.1.1 Europe RNA Vaccines Sales by Type (2017-2028)
7.1.2 Europe RNA Vaccines Revenue by Type (2017-2028)
7.2 Europe RNA Vaccines Market Size by Application
7.2.1 Europe RNA Vaccines Sales by Application (2017-2028)
7.2.2 Europe RNA Vaccines Revenue by Application (2017-2028)
7.3 Europe RNA Vaccines Market Size by Country
7.3.1 Europe RNA Vaccines Sales by Country (2017-2028)
7.3.2 Europe RNA Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific RNA Vaccines Market Size by Type
8.1.1 Asia Pacific RNA Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific RNA Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific RNA Vaccines Market Size by Application
8.2.1 Asia Pacific RNA Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific RNA Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific RNA Vaccines Market Size by Region
8.3.1 Asia Pacific RNA Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific RNA Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America RNA Vaccines Market Size by Type
9.1.1 Latin America RNA Vaccines Sales by Type (2017-2028)
9.1.2 Latin America RNA Vaccines Revenue by Type (2017-2028)
9.2 Latin America RNA Vaccines Market Size by Application
9.2.1 Latin America RNA Vaccines Sales by Application (2017-2028)
9.2.2 Latin America RNA Vaccines Revenue by Application (2017-2028)
9.3 Latin America RNA Vaccines Market Size by Country
9.3.1 Latin America RNA Vaccines Sales by Country (2017-2028)
9.3.2 Latin America RNA Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa RNA Vaccines Market Size by Type
10.1.1 Middle East and Africa RNA Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa RNA Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa RNA Vaccines Market Size by Application
10.2.1 Middle East and Africa RNA Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa RNA Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa RNA Vaccines Market Size by Country
10.3.1 Middle East and Africa RNA Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa RNA Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Corporation Information
11.1.2 Moderna Therapeutics Overview
11.1.3 Moderna Therapeutics RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Moderna Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Therapeutics Recent Developments
11.2 CureVac
11.2.1 CureVac Corporation Information
11.2.2 CureVac Overview
11.2.3 CureVac RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CureVac RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CureVac Recent Developments
11.3 Translate Bio
11.3.1 Translate Bio Corporation Information
11.3.2 Translate Bio Overview
11.3.3 Translate Bio RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Translate Bio RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Translate Bio Recent Developments
11.4 BioNTech
11.4.1 BioNTech Corporation Information
11.4.2 BioNTech Overview
11.4.3 BioNTech RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BioNTech RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BioNTech Recent Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Corporation Information
11.5.2 Sangamo Therapeutics Overview
11.5.3 Sangamo Therapeutics RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sangamo Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sangamo Therapeutics Recent Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Corporation Information
11.6.2 Argos Therapeutics Overview
11.6.3 Argos Therapeutics RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Argos Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Argos Therapeutics Recent Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Corporation Information
11.7.2 In-Cell-Art Overview
11.7.3 In-Cell-Art RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 In-Cell-Art RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 In-Cell-Art Recent Developments
11.8 eTheRNA
11.8.1 eTheRNA Corporation Information
11.8.2 eTheRNA Overview
11.8.3 eTheRNA RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 eTheRNA RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 eTheRNA Recent Developments
11.9 Ethris
11.9.1 Ethris Corporation Information
11.9.2 Ethris Overview
11.9.3 Ethris RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ethris RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ethris Recent Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Corporation Information
11.10.2 Tiba Biotechnology Overview
11.10.3 Tiba Biotechnology RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Tiba Biotechnology RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tiba Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 RNA Vaccines Industry Chain Analysis
12.2 RNA Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 RNA Vaccines Production Mode & Process
12.4 RNA Vaccines Sales and Marketing
12.4.1 RNA Vaccines Sales Channels
12.4.2 RNA Vaccines Distributors
12.5 RNA Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 RNA Vaccines Industry Trends
13.2 RNA Vaccines Market Drivers
13.3 RNA Vaccines Market Challenges
13.4 RNA Vaccines Market Restraints
14 Key Findings in The Global RNA Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global RNA Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine
Table 3. Major Manufacturers of Infectious Disease Treatment MRNA Vaccine
Table 4. Major Manufacturers of Infection Prevention MRNA Vaccine
Table 5. Global RNA Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global RNA Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global RNA Vaccines Sales by Region (2017-2022) & (K Doses)
Table 8. Global RNA Vaccines Sales Market Share by Region (2017-2022)
Table 9. Global RNA Vaccines Sales by Region (2023-2028) & (K Doses)
Table 10. Global RNA Vaccines Sales Market Share by Region (2023-2028)
Table 11. Global RNA Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global RNA Vaccines Revenue Market Share by Region (2017-2022)
Table 13. Global RNA Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global RNA Vaccines Revenue Market Share by Region (2023-2028)
Table 15. Global RNA Vaccines Sales by Manufacturers (2017-2022) & (K Doses)
Table 16. Global RNA Vaccines Sales Share by Manufacturers (2017-2022)
Table 17. Global RNA Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global RNA Vaccines Revenue Share by Manufacturers (2017-2022)
Table 19. RNA Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)
Table 20. Global RNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global RNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Vaccines as of 2021)
Table 22. RNA Vaccines Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers RNA Vaccines Product Offered
Table 24. Date of Manufacturers Enter into RNA Vaccines Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 27. Global RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 28. Global RNA Vaccines Sales Share by Type (2017-2022)
Table 29. Global RNA Vaccines Sales Share by Type (2023-2028)
Table 30. Global RNA Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global RNA Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global RNA Vaccines Revenue Share by Type (2017-2022)
Table 33. Global RNA Vaccines Revenue Share by Type (2023-2028)
Table 34. RNA Vaccines Price by Type (2017-2022) & (USD/Dose)
Table 35. Global RNA Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)
Table 36. Global RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 37. Global RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 38. Global RNA Vaccines Sales Share by Application (2017-2022)
Table 39. Global RNA Vaccines Sales Share by Application (2023-2028)
Table 40. Global RNA Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global RNA Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global RNA Vaccines Revenue Share by Application (2017-2022)
Table 43. Global RNA Vaccines Revenue Share by Application (2023-2028)
Table 44. RNA Vaccines Price by Application (2017-2022) & (USD/Dose)
Table 45. Global RNA Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)
Table 46. North America RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 47. North America RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 48. North America RNA Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America RNA Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 51. North America RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 52. North America RNA Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America RNA Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America RNA Vaccines Sales by Country (2017-2022) & (K Doses)
Table 55. North America RNA Vaccines Sales by Country (2023-2028) & (K Doses)
Table 56. North America RNA Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America RNA Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 59. Europe RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 60. Europe RNA Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe RNA Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 63. Europe RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 64. Europe RNA Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe RNA Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe RNA Vaccines Sales by Country (2017-2022) & (K Doses)
Table 67. Europe RNA Vaccines Sales by Country (2023-2028) & (K Doses)
Table 68. Europe RNA Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe RNA Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 71. Asia Pacific RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 72. Asia Pacific RNA Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific RNA Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 75. Asia Pacific RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 76. Asia Pacific RNA Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific RNA Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific RNA Vaccines Sales by Region (2017-2022) & (K Doses)
Table 79. Asia Pacific RNA Vaccines Sales by Region (2023-2028) & (K Doses)
Table 80. Asia Pacific RNA Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific RNA Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 83. Latin America RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 84. Latin America RNA Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America RNA Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 87. Latin America RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 88. Latin America RNA Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America RNA Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America RNA Vaccines Sales by Country (2017-2022) & (K Doses)
Table 91. Latin America RNA Vaccines Sales by Country (2023-2028) & (K Doses)
Table 92. Latin America RNA Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America RNA Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 95. Middle East and Africa RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 96. Middle East and Africa RNA Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa RNA Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 99. Middle East and Africa RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 100. Middle East and Africa RNA Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa RNA Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa RNA Vaccines Sales by Country (2017-2022) & (K Doses)
Table 103. Middle East and Africa RNA Vaccines Sales by Country (2023-2028) & (K Doses)
Table 104. Middle East and Africa RNA Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa RNA Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 106. Moderna Therapeutics Corporation Information
Table 107. Moderna Therapeutics Description and Major Businesses
Table 108. Moderna Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 109. Moderna Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Moderna Therapeutics Recent Developments
Table 111. CureVac Corporation Information
Table 112. CureVac Description and Major Businesses
Table 113. CureVac RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 114. CureVac RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. CureVac Recent Developments
Table 116. Translate Bio Corporation Information
Table 117. Translate Bio Description and Major Businesses
Table 118. Translate Bio RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 119. Translate Bio RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Translate Bio Recent Developments
Table 121. BioNTech Corporation Information
Table 122. BioNTech Description and Major Businesses
Table 123. BioNTech RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 124. BioNTech RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. BioNTech Recent Developments
Table 126. Sangamo Therapeutics Corporation Information
Table 127. Sangamo Therapeutics Description and Major Businesses
Table 128. Sangamo Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 129. Sangamo Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Sangamo Therapeutics Recent Developments
Table 131. Argos Therapeutics Corporation Information
Table 132. Argos Therapeutics Description and Major Businesses
Table 133. Argos Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 134. Argos Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Argos Therapeutics Recent Developments
Table 136. In-Cell-Art Corporation Information
Table 137. In-Cell-Art Description and Major Businesses
Table 138. In-Cell-Art RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 139. In-Cell-Art RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. In-Cell-Art Recent Developments
Table 141. eTheRNA Corporation Information
Table 142. eTheRNA Description and Major Businesses
Table 143. eTheRNA RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 144. eTheRNA RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. eTheRNA Recent Developments
Table 146. Ethris Corporation Information
Table 147. Ethris Description and Major Businesses
Table 148. Ethris RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 149. Ethris RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Ethris Recent Developments
Table 151. Tiba Biotechnology Corporation Information
Table 152. Tiba Biotechnology Description and Major Businesses
Table 153. Tiba Biotechnology RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 154. Tiba Biotechnology RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Tiba Biotechnology Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. RNA Vaccines Distributors List
Table 159. RNA Vaccines Customers List
Table 160. RNA Vaccines Market Trends
Table 161. RNA Vaccines Market Drivers
Table 162. RNA Vaccines Market Challenges
Table 163. RNA Vaccines Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Vaccines Product Picture
Figure 3. Global RNA Vaccines Market Share by Type in 2021 & 2028
Figure 3. Individualized Cancer Treatment MRNA Vaccine Product Picture
Figure 4. Infectious Disease Treatment MRNA Vaccine Product Picture
Figure 5. Infection Prevention MRNA Vaccine Product Picture
Figure 6. Global RNA Vaccines Market Share by Application in 2021 & 2028
Figure 7. Infectious Disease
Figure 8. Cancer
Figure 9. Other
Figure 10. RNA Vaccines Report Years Considered
Figure 11. Global RNA Vaccines Sales 2017-2028 (K Doses)
Figure 12. Global RNA Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global RNA Vaccines Revenue 2017-2028 (US$ Million)
Figure 14. Global RNA Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global RNA Vaccines Sales Market Share by Region (2017-2022)
Figure 16. Global RNA Vaccines Sales Market Share by Region (2023-2028)
Figure 17. North America RNA Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 18. North America RNA Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe RNA Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 20. Europe RNA Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific RNA Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 22. Asia-Pacific RNA Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America RNA Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 24. Latin America RNA Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa RNA Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 26. Middle East & Africa RNA Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The RNA Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of RNA Vaccines in the World: Market Share by RNA Vaccines Revenue in 2021
Figure 29. Global RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global RNA Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global RNA Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. North America RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 35. North America RNA Vaccines Revenue Market Share by Type (2017-2028)
Figure 36. North America RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America RNA Vaccines Revenue Market Share by Application (2017-2028)
Figure 38. North America RNA Vaccines Sales Share by Country (2017-2028)
Figure 39. North America RNA Vaccines Revenue Share by Country (2017-2028)
Figure 40. U.S. RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 41. Canada RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 42. Europe RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe RNA Vaccines Revenue Market Share by Type (2017-2028)
Figure 44. Europe RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe RNA Vaccines Revenue Market Share by Application (2017-2028)
Figure 46. Europe RNA Vaccines Sales Share by Country (2017-2028)
Figure 47. Europe RNA Vaccines Revenue Share by Country (2017-2028)
Figure 48. Germany RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. France RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Italy RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 52. Russia RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific RNA Vaccines Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific RNA Vaccines Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific RNA Vaccines Sales Share by Region (2017-2028)
Figure 58. Asia Pacific RNA Vaccines Revenue Share by Region (2017-2028)
Figure 59. China RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 60. Japan RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 62. India RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Australia RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 70. Latin America RNA Vaccines Revenue Market Share by Type (2017-2028)
Figure 71. Latin America RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 72. Latin America RNA Vaccines Revenue Market Share by Application (2017-2028)
Figure 73. Latin America RNA Vaccines Sales Share by Country (2017-2028)
Figure 74. Latin America RNA Vaccines Revenue Share by Country (2017-2028)
Figure 75. Mexico RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa RNA Vaccines Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa RNA Vaccines Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa RNA Vaccines Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa RNA Vaccines Revenue Share by Country (2017-2028)
Figure 84. Turkey RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E RNA Vaccines Revenue (2017-2028) & (US$ Million)
Figure 87. RNA Vaccines Value Chain
Figure 88. RNA Vaccines Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $4667

Multi User Price : $7000

Enterprise Price : $9333

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global RNA Vaccines Market Insights, Forecast to 2028